Fonar Current Ratio 2006-2019 | FONR

Fonar current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Fonar Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.09B $0.01B 6.25
2019-06-30 $0.09B $0.01B 6.04
2019-03-31 $0.08B $0.01B 6.99
2018-12-31 $0.07B $0.01B 6.33
2018-09-30 $0.07B $0.01B 5.99
2018-06-30 $0.07B $0.02B 4.60
2018-03-31 $0.06B $0.01B 4.96
2017-12-31 $0.06B $0.01B 4.43
2017-09-30 $0.06B $0.01B 4.05
2017-06-30 $0.05B $0.01B 3.75
2017-03-31 $0.05B $0.01B 3.52
2016-12-31 $0.05B $0.02B 2.81
2016-09-30 $0.05B $0.02B 2.57
2016-06-30 $0.05B $0.02B 2.21
2016-03-31 $0.05B $0.02B 2.74
2015-12-31 $0.05B $0.02B 2.57
2015-09-30 $0.05B $0.02B 2.38
2015-06-30 $0.04B $0.02B 2.32
2015-03-31 $0.04B $0.02B 2.13
2014-12-31 $0.05B $0.02B 2.24
2014-09-30 $0.05B $0.02B 2.07
2014-06-30 $0.04B $0.02B 2.05
2014-03-31 $0.04B $0.02B 1.95
2013-12-31 $0.04B $0.02B 1.88
2013-09-30 $0.04B $0.02B 1.84
2013-06-30 $0.04B $0.02B 1.79
2013-03-31 $0.04B $0.02B 1.63
2012-12-31 $0.03B $0.02B 1.38
2012-09-30 $0.03B $0.02B 1.30
2012-06-30 $0.03B $0.02B 1.23
2012-03-31 $0.03B $0.02B 1.20
2011-12-31 $0.03B $0.02B 1.15
2011-09-30 $0.02B $0.02B 1.06
2011-06-30 $0.02B $0.02B 0.98
2011-03-31 $0.02B $0.02B 0.70
2010-12-31 $0.02B $0.03B 0.61
2010-09-30 $0.02B $0.03B 0.61
2010-06-30 $0.02B $0.03B 0.59
2010-03-31 $0.02B $0.03B 0.59
2009-12-31 $0.02B $0.03B 0.59
2009-09-30 $0.02B $0.03B 0.64
2009-06-30 $0.02B $0.03B 0.63
2009-03-31 $0.02B $0.03B 0.60
2008-12-31 $0.02B $0.04B 0.58
2008-09-30 $0.02B $0.04B 0.56
2008-06-30 $0.02B $0.04B 0.58
2008-03-31 $0.02B $0.04B 0.65
2007-12-31 $0.02B $0.04B 0.69
2007-09-30 $0.02B $0.03B 0.76
2007-06-30 $0.02B $0.03B 0.75
2007-03-31 $0.03B $0.03B 1.03
2006-12-31 $0.04B $0.03B 1.22
2006-09-30 $0.04B $0.02B 1.46
2006-06-30 $0.04B $0.03B 1.58
2006-03-31 $0.04B $0.02B 2.00
2005-12-31 $0.05B $0.02B 2.27
2005-09-30 $0.05B $0.02B 2.51
2005-06-30 $0.06B $0.02B 2.62
2005-03-31 $0.06B $0.02B 2.46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.127B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.956B 20.58
Abbott Laboratories (ABT) United States $148.320B 27.06
Stryker (SYK) United States $74.970B 25.21
Boston Scientific (BSX) United States $60.924B 28.76
Baxter (BAX) United States $41.636B 25.25
Essilor Luxottica (ESLOY) France $33.188B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.178B 18.93
Terumo (TRUMY) Japan $26.560B 33.15
Lonza Group Ag (LZAGY) Switzerland $25.341B 0.00
Coloplast (CLPBY) Denmark $25.099B 38.73
ResMed (RMD) United States $21.470B 39.61
Smith & Nephew SNATS (SNN) United Kingdom $19.270B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.169B 531.35
Bio-Rad Laboratories (BIO) United States $10.705B 51.38
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Canopy Growth (CGC) Canada $7.421B 0.00
Perrigo (PRGO) Ireland $7.212B 13.45
Hill-Rom Holdings (HRC) United States $7.115B 20.98
Haemonetics (HAE) United States $5.955B 40.24
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.869B 30.46
ICU Medical (ICUI) United States $3.704B 24.15
Neogen (NEOG) United States $3.501B 58.58
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.090B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.969B 0.00
Quidel (QDEL) United States $2.961B 28.10
Aurora Cannabis (ACB) Canada $2.855B 0.00
Agios Pharmaceuticals (AGIO) United States $2.471B 0.00
National Vision Holdings (EYE) United States $2.404B 54.25
Cardiovascular Systems (CSII) United States $1.562B 0.00
InMode (INMD) Israel $1.365B 0.00
Aphria (APHA) $1.278B 0.00
AtriCure (ATRC) United States $1.204B 0.00
VAREX IMAGING (VREX) United States $1.154B 23.11
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.937B 0.00
TG Therapeutics (TGTX) United States $0.924B 0.00
Lantheus Holdings (LNTH) United States $0.794B 19.84
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.75
Quanterix (QTRX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.686B 38.53
PetIQ (PETQ) United States $0.685B 16.70
Omeros (OMER) United States $0.654B 0.00
HEXO (HEXO) $0.589B 0.00
Surmodics (SRDX) United States $0.555B 57.72
Cerus (CERS) United States $0.543B 0.00
OraSure Technologies (OSUR) United States $0.487B 29.22
Owens & Minor (OMI) United States $0.484B 17.91
MacroGenics (MGNX) United States $0.481B 0.00
Organigram Holdings (OGI) Canada $0.420B 0.00
Meridian Bioscience (VIVO) United States $0.400B 13.77
Utah Medical Products (UTMD) United States $0.384B 27.83
BioLife Solutions (BLFS) United States $0.320B 130.50
Zynex (ZYXI) United States $0.313B 35.44
Bovie Medical (APYX) United States $0.271B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.261B 0.00
United Health Products (UEEC) United States $0.246B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.20
Repro-Med Systems (KRMD) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.226B 0.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.151B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
MTech Acquisition (KERN) United States $0.129B 0.00
Cytosorbents (CTSO) United States $0.122B 0.00
United-Guardian (UG) United States $0.090B 22.77
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Chembio Diagnostics (CEMI) United States $0.073B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00